Sprinklr gives data to company that researches on anti-COVID vaccine; controversy intensifies


Seeji Kadakkal / Mathrubhumi News

The link between these two companies came to light when allegations arose that the data collected by Sprinklr may be leaked to pharmaceutical companies.

Representational Image | Photo: screen grab|mathrubhumi news

Thiruvananthapuram: A report has come to light revealing Sprinklr company that was mired in the data leaking controversy has connections with the international pharmaceutical company Pfizer which is researching on anti-COVID vaccines. It is also pointed out that the company had sought details of COVID-19 positive patients. Mathrubhumi News disclosed the evidences of these links.

Pfizer had sought help of Sprinklr to collect data of patients and to increase the value of Pfizer. The link between these two companies came to light when allegations arose that the data collected by Sprinklr may be leaked to pharmaceutical companies. Pfizer claims that they produce anti-COVID vaccine and medicine. The official website of the company also confirms this.

Pfizer company had already admitted that they received data of the patients and their requirements through Sprinklr company. This was made clear by Sarah Holiday, the Social Media Strategy Lead of Pfizer, in an interview given in 2017. Sarah Holiday has already stated that the fuel of the 21st century is data. Market website that reveals new updates in health sector also mentions about the links of Sprinklr with Pfizer.

Add Comment
Related Topics

Get daily updates from Mathrubhumi.com

Youtube
Telegram
Disclaimer: Kindly avoid objectionable, derogatory, unlawful and lewd comments, while responding to reports. Such comments are punishable under cyber laws. Please keep away from personal attacks. The opinions expressed here are the personal opinions of readers and not that of Mathrubhumi.